Status:
UNKNOWN
Optimizing CO2 Injection Technique for EVAR
Lead Sponsor:
University of Bologna
Conditions:
Abdominal Aortic Aneurysm
Endovascular Aortic Repair
Eligibility:
All Genders
18-100 years
Brief Summary
Automated carbon dioxide (CO2) angiography is considered a safe diagnostic alternative to standard iodinated contrast medium (ICM) for endovascular aortic repair (EVAR) of abdominal aortic aneurysm (A...
Detailed Description
Endovascular aneurysm repair is currently a wide spread therapeutic option due to a lower 30-day morbidity/mortality compared with open repair (OR), especially in patients with high surgical risk. The...
Eligibility Criteria
Inclusion
- Patients with asymptomatic infrarenal abdominal aortic aneurysm admitted to the S. Orsola - Malpighi Hospital for a planned EVAR procedure. All patients underwent a preoperative computed tomography angiography (CTA) with a \<2mm slices.
Exclusion
- Patients with contraindication for CO2 (cardiac septal defects, pulmonary arteriovenous malformations, pulmonary hypertension, severe emphysema)
- Patients requiring advanced aortic repair (FEVAR, BEVAR)
- Urgent cases
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 15 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05304026
Start Date
January 1 2021
End Date
September 15 2022
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Bologna
Bologna, Emilia-Romagna, Italy, 40138